Association of Biomarkers with Serious Cardiac Adverse Events during Abiraterone Acetate Treatment in Castration Resistant Prostate Cancer

Association of Biomarkers with Serious Cardiac Adverse Events during Abiraterone Acetate Treatment in Castration Resistant Prostate Cancer

BACKGROUND: Abiraterone acetate is an effective drug for castration-resistant prostate cancer, but cardiac serious adverse events (SAEs) may occur. We studied their association with N-terminal pro–brain natriuretic peptide (NT-proBNP) and troponin T (TnT) during abiraterone therapy. PATIENTS AND MET...

Full description

Bibliographic Details
Main Authors: Campora, Sara, Campazzi, Eleonora, Zanardi, Silvia, Puntoni, Matteo, Piccininno, Marco, Piccardo, Arnoldo, Shoushtari Zadeh Naseri, Mehrdad, Defferrari, Carlotta, Provinciali, Nicoletta, Petrera, Marilena, Marra, Domenico, Biscaldi, Ennio, Antonucci, Gian Carlo, Ricci, Damiano, Clavarezza, Matteo, Gennari, Alessandra, Gozza, Alberto, D'Amico, Mauro, Mori, Marco, DeCensi, Andrea
Format: Online
Language:English
Published: Neoplasia Press 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143350/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143350/

Similar Items